Billy Roberts

1.4k total citations
15 papers, 649 citations indexed

About

Billy Roberts is a scholar working on Oncology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Billy Roberts has authored 15 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Organic Chemistry and 5 papers in Molecular Biology. Recurrent topics in Billy Roberts's work include Solar Radiation and Photovoltaics (4 papers), Cancer therapeutics and mechanisms (4 papers) and HER2/EGFR in Cancer Research (3 papers). Billy Roberts is often cited by papers focused on Solar Radiation and Photovoltaics (4 papers), Cancer therapeutics and mechanisms (4 papers) and HER2/EGFR in Cancer Research (3 papers). Billy Roberts collaborates with scholars based in United States and New Zealand. Billy Roberts's co-authors include Wilbur R. Leopold, William L. Elliott, James M. Nelson, H. D. Hollis Showalter, David W. Fry, Patrick W. Vincent, Robert Jackson, R. Thomas Winters, Gordon W. Rewcastle and William A. Denny and has published in prestigious journals such as Journal of Medicinal Chemistry, Solar Energy and Cancer Chemotherapy and Pharmacology.

In The Last Decade

Billy Roberts

15 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Billy Roberts United States 11 289 284 266 87 62 15 649
John Ramphal United States 11 244 0.8× 170 0.6× 466 1.8× 87 1.0× 27 0.4× 19 816
Diane E. Gingrich United States 15 226 0.8× 251 0.9× 350 1.3× 101 1.2× 18 0.3× 25 678
Robert H. Gruninger United States 13 345 1.2× 234 0.8× 252 0.9× 74 0.9× 44 0.7× 14 704
Ted L. Underiner United States 18 331 1.1× 154 0.5× 388 1.5× 96 1.1× 17 0.3× 31 763
Karen L. Milkiewicz United States 14 266 0.9× 281 1.0× 384 1.4× 37 0.4× 21 0.3× 19 649
Lianshan Zhang China 18 107 0.4× 339 1.2× 352 1.3× 170 2.0× 83 1.3× 38 843
Venkat R. Pallela United States 17 278 1.0× 208 0.7× 246 0.9× 73 0.8× 186 3.0× 25 738
Kazuhide Nakamura Japan 18 159 0.6× 249 0.9× 601 2.3× 132 1.5× 60 1.0× 27 1.0k
Timothy P. Heffron United States 14 297 1.0× 200 0.7× 322 1.2× 167 1.9× 35 0.6× 21 808
Asaad Nematalla United States 7 240 0.8× 123 0.4× 269 1.0× 101 1.2× 23 0.4× 13 547

Countries citing papers authored by Billy Roberts

Since Specialization
Citations

This map shows the geographic impact of Billy Roberts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Billy Roberts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Billy Roberts more than expected).

Fields of papers citing papers by Billy Roberts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Billy Roberts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Billy Roberts. The network helps show where Billy Roberts may publish in the future.

Co-authorship network of co-authors of Billy Roberts

This figure shows the co-authorship network connecting the top 25 collaborators of Billy Roberts. A scholar is included among the top collaborators of Billy Roberts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Billy Roberts. Billy Roberts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bodini, Nicola, Mike Optis, Stephanie Redfern, et al.. (2024). The 2023 National Offshore Wind data set (NOW-23). Earth system science data. 16(4). 1965–2006. 14 indexed citations
2.
Habte, Aron, Manajit Sengupta, Yu Xie, et al.. (2022). The National Solar Radiation Database (NSRDB): Current Status. 2022 IEEE 49th Photovoltaics Specialists Conference (PVSC). 480–480. 5 indexed citations
3.
4.
Maclaurin, Galen, et al.. (2018). Understanding Inter-Annual Variability of PV Energy Production in the Contiguous United States. 1–4. 5 indexed citations
5.
6.
Vincent, Patrick W., Alex Bridges, Donald J. Dykes, et al.. (2000). Anticancer efficacy of the irreversible EGFr tyrosine kinase inhibitor PD 0169414 against human tumor xenografts. Cancer Chemotherapy and Pharmacology. 45(3). 231–238. 37 indexed citations
7.
Smaill, Jeff B., Brian D. Palmer, Gordon W. Rewcastle, et al.. (1999). Tyrosine Kinase Inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(Phenylamino)pyrido[d]pyrimidine Acrylamides as Irreversible Inhibitors of the ATP Binding Site of the Epidermal Growth Factor Receptor. Journal of Medicinal Chemistry. 42(10). 1803–1815. 158 indexed citations
8.
9.
Kunkel, Mark W., Kenneth E. Hook, Sally Przybranowski, et al.. (1995). Inhibition of the epidermal growth factor receptor tyrosine kinase by PD153035 in human A431 tumors in athymic nude mice. Investigational New Drugs. 13(4). 295–302. 55 indexed citations
10.
Hoeschele, James D., H. D. Hollis Showalter, Alan J. Kraker, et al.. (1994). Synthesis, Structural Characterization, and Antitumor Properties of a Novel Class of Large-Ring Platinum(II) Chelate Complexes Incorporating the cis-1,4-Diaminocyclohexane Ligand in a Unique Locked Boat Conformation. Journal of Medicinal Chemistry. 37(17). 2630–2636. 59 indexed citations
11.
Kraker, Alan J., Charles Watson Moore, Billy Roberts, Wilbur R. Leopold, & William L. Elliott. (1991). Preclinical antitumor activity of CI-973,[SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)] (2 methyl-1,4-butane-diamine-N,N′)platinum. Investigational New Drugs. 9(1). 1–8. 9 indexed citations
12.
Jackson, Robert, David W. Fry, Theodore J. Boritzki, et al.. (1985). The biochemical pharmacology of CI-920, a structurally novel antibiotic with antileukemic activity. Advances in Enzyme Regulation. 23. 193–215. 37 indexed citations
13.
Leopold, Wilbur R., et al.. (1984). Anticancer activity of the structurally novel antibiotic Cl-920 and its analogues.. PubMed. 44(5). 1928–32. 70 indexed citations
14.
Corbett, Thomas H., Wilbur R. Leopold, Donald J. Dykes, et al.. (1982). Toxicity and anticancer activity of a new triazine antifolate (NSC 127755).. PubMed. 42(5). 1707–15. 59 indexed citations
15.
Corbett, Thomas H., Daniel P. Griswold, Billy Roberts, & Frank M. Schabel. (1981). Absence of delayed lethality in mice treated with aclacinomycin A. Cancer Chemotherapy and Pharmacology. 6(2). 161–168. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John Ramphal Breakdown of academic impact, for papers by Diane E. Gingrich Breakdown of academic impact, for papers by Robert H. Gruninger Breakdown of academic impact, for papers by Ted L. Underiner Breakdown of academic impact, for papers by Karen L. Milkiewicz Breakdown of academic impact, for papers by Lianshan Zhang Breakdown of academic impact, for papers by Venkat R. Pallela Breakdown of academic impact, for papers by Kazuhide Nakamura Breakdown of academic impact, for papers by Timothy P. Heffron Breakdown of academic impact, for papers by Asaad Nematalla
Rankless by CCL
2026